German Heart Foundation

German Heart Foundation
Name	German Heart Foundation
Native name	Stiftung Deutsche Herzstiftung
Founded	1971
Founder	Hans-Joachim Maaz; Franz Josef Strauß (supporters)
Type	Non-profit foundation
Headquarters	Frankfurt am Main
Area served	Germany
Focus	Cardiovascular research, patient education, prevention

German Heart Foundation is a German non-profit foundation dedicated to prevention, research, and patient support in the field of cardiovascular disease. Established in the early 1970s, the foundation operates at the intersection of clinical practice, biomedical research, and public health outreach, engaging with hospitals, universities, and patient organizations. Its activities include grantmaking for scientific projects, public campaigns about risk factors, and direct services for people affected by myocardial infarction, arrhythmia, and heart failure.

History

The foundation traces roots to initiatives in the 1960s and 1970s that sought to coordinate responses to rising rates of ischemic heart disease in West Germany and across Europe. Early supporters included political figures linked to Christian Social Union in Bavaria and physicians associated with academic centers such as Charité – Universitätsmedizin Berlin and Universitätsklinikum Heidelberg. During the 1980s and 1990s the foundation expanded links with research institutions like Max Planck Society, Helmholtz Association, and university cardiology departments at Ludwig Maximilian University of Munich and University of Cologne. It has responded to major developments in cardiology, including the proliferation of percutaneous coronary intervention after innovations at institutions like Massachusetts General Hospital and the emergence of heart failure therapies influenced by trials from Mayo Clinic and Cleveland Clinic. The foundation’s archive documents collaborations with international bodies such as the World Heart Federation and participation in European initiatives tied to the European Society of Cardiology.

Mission and Activities

The foundation’s stated mission aligns with objectives promoted by bodies like the World Health Organization concerning noncommunicable diseases. It emphasizes prevention of coronary artery disease, stroke, and sudden cardiac death through campaigns modeled on programs from the American Heart Association and the British Heart Foundation. Core activities include issuing patient-oriented guidance similar to recommendations from the European Medicines Agency and supporting guideline development in cooperation with specialty societies such as the German Cardiac Society and the European Society of Cardiology. The foundation also monitors health policy debates at institutions like the Bundestag and engages with statutory insurers such as AOK and Techniker Krankenkasse on access to diagnostics and therapies.

Research and Funding

Research funding targets translational projects spanning basic science labs in the tradition of the Max Planck Institute for Heart and Lung Research, clinical trials at university hospitals like Charité – Universitätsmedizin Berlin, and population studies comparable to the Framingham Heart Study and the MONICA Project. The foundation has awarded grants to investigators working on myocardial regeneration, arrhythmia mechanisms, lipid metabolism, and device therapy, with connections to biotechnology firms in the BioRN cluster and spin-offs from Helmholtz Zentrum München. It participates in multicenter registries and supports young investigators through fellowships modeled after programs at the German Research Foundation and the European Research Council. The foundation has contributed to randomized trials and cohort research that interface with regulatory assessments at the European Medicines Agency.

Public Education and Prevention Programs

Public campaigns emphasize modifiable risk factors highlighted by landmark studies from Framingham Heart Study, promoting tobacco cessation strategies used by organizations like World Heart Federation and dietary advice reflecting guidelines from World Health Organization and experts at Harvard T.H. Chan School of Public Health. The foundation organizes nationwide screening initiatives in cooperation with municipal health offices in cities such as Berlin, Hamburg, and Munich, and runs awareness events aligned with global observances like World Heart Day. Educational materials for patients and families echo patient resources published by the American College of Cardiology and the European Society of Cardiology and are distributed through clinics affiliated with universities including University of Freiburg.

Patient Support and Advocacy

Services include helplines, peer-support networks, and informational brochures for conditions such as myocardial infarction, heart failure, and congenital heart disease. The foundation advocates for patient rights in forums alongside organizations like Deutsche Stiftung Patientenschutz and cooperates with self-help groups linked to hospitals such as Universitätsklinikum Bonn. It campaigns for access to advanced therapies including implantable cardioverter-defibrillators and mechanical circulatory support devices developed by companies associated with innovation hubs around Stuttgart and Berlin. The foundation contributes expert testimony to regulatory deliberations at bodies such as the Federal Joint Committee (G-BA).

Organizational Structure and Leadership

Governance follows a foundation model common in Germany, with a board of trustees and an executive director, and scientific advisory boards comprised of clinicians and researchers from centers including Charité – Universitätsmedizin Berlin, Heidelberg University Hospital, and University Hospital Frankfurt. Past leaders have included prominent cardiologists with affiliations to the German Cardiac Society and European societies. Financial oversight and audit functions comply with standards applied by institutions like the Bundesrechnungshof and reporting frameworks used by major foundations in Germany.

Collaborations and Partnerships

The foundation maintains partnerships with academic institutions such as Ludwig Maximilian University of Munich, research organizations including the Max Planck Society and Helmholtz Association, professional societies like the German Cardiac Society and European Society of Cardiology, and patient groups across Germany. It engages in multinational projects with entities like the World Heart Federation and European research consortia funded through frameworks reminiscent of the Horizon Europe program. Industry collaborations involve medical technology firms active in regions such as Baden-Württemberg and Berlin, and pharmaceutical partners engaged in cardiovascular drug development.

Category:Heart disease organizations